Position in NTLA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$8,311,543
+$7,406,977 QoQ
Shares Held
491,226
+596.2% QoQ
Ownership
0.351%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#45
of 330 holders
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NTLA Over Time
Shares Held
Position Value (USD)
Derivatives in NTLA
reported options exposure · as of Dec 31, 2022CallValue
$2,187,603
CallShares
62,700
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026MILLENNIUM MANAGEMENT LLC holds $4,631,421,099 across 322 Biotechnology names. NTLA ranks #129 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
468,410 | $232,673,299 | |
| 2 | INSM |
INSMED Inc
|
2,048,005 | $218,358,293 | |
| 3 | APGE |
Apogee Therapeutics, Inc.
|
1,491,404 | $197,954,052 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
763,880 | $184,072,163 | |
| 5 | ONC |
BeOne Medicines Ltd.
|
543,323 | $154,830,755 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
556,088 | $136,113,659 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
2,071,816 | $118,549,311 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
165,120 | $102,958,924 |
All Filings in NTLA
Export CSV
35 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,311,543 | 491,226 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $904,566 | 70,559 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,136,569 | 126,426 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $10,492,613 | 607,563 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $7,794,836 | 831,006 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $4,169,936 | 586,489 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $7,799,677 | 668,926 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $4,732,685 | 230,301 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,693,584 | 75,674 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $4,920,961 | 178,879 | Shares | Sole | 2024-05-15 | |
| 2023-09-30 | $7,366,859 | 232,981 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $6,136,655 | 150,482 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $11,180,627 | 299,990 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,748,721 | 50,121 | Shares | Sole | 2023-02-14 | |
| 2022-12-31 | $2,187,603 | 62,700 | Call | Sole | 2023-02-14 | |
| 2022-09-30 | $18,491,534 | 330,442 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $18,601,974 | 359,389 | Shares | Sole | 2022-08-15 | |
| 2022-06-30 | $543,480 | 10,500 | Call | Sole | 2022-08-15 | |
| 2022-06-30 | $6,754,680 | 130,500 | Put | Sole | 2022-08-15 | |
| 2022-03-31 | $36,354,330 | 500,266 | Shares | Sole | 2022-05-16 | |
| 2022-03-31 | $3,633,500 | 50,000 | Put | Sole | 2022-05-16 | |
| 2021-12-31 | $591,200 | 5,000 | Put | Sole | 2022-02-14 | |
| 2021-12-31 | $1,255,827 | 10,621 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $13,719,118 | 102,267 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $10,524,150 | 65,000 | Call | Sole | 2021-08-16 | |
| 2021-06-30 | $16,806,258 | 103,800 | Put | Sole | 2021-08-16 | |
| 2021-06-30 | $28,698,547 | 177,250 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $5,497,467 | 68,500 | Call | Sole | 2021-05-17 | |
| 2021-03-31 | $2,022,426 | 25,200 | Put | Sole | 2021-05-17 | |
| 2021-03-31 | $34,487,660 | 429,726 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $17,877,961 | 328,639 | Shares | Sole | 2021-02-16 | |
| 2020-12-31 | $272,000 | 5,000 | Put | Sole | 2021-02-16 | |
| 2020-12-31 | $544,000 | 10,000 | Call | Sole | 2021-02-16 | |
| 2020-09-30 | $9,242,589 | 464,919 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $2,867,653 | 136,425 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||